img

Global Non-Benzodiazepines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Non-Benzodiazepines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Non-benzodiazepines are a relatively new class of hypnotics
Non-Benzodiazepines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Non-Benzodiazepines market is projected to reach US$ 1436.9 million in 2034, increasing from US$ 650 million in 2022, with the CAGR of 12.0% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Non-Benzodiazepines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Non-Benzodiazepines key manufacturers include Pfizer, Teva Pharmaceuticals, Torrent Pharma, Accord Healthcare, Akorn, Apotex, Fresenius Kabi, Hikma and Mylan, etc. Pfizer, Teva Pharmaceuticals, Torrent Pharma are top 3 players and held % sales share in total in 2022.
Non-Benzodiazepines can be divided into Dexmedetomidine, Zolpidem, Eszopiclone and Zopiclone, etc. Dexmedetomidine is the mainstream product in the market, accounting for % sales share globally in 2022.
Non-Benzodiazepines is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Non-Benzodiazepines industry development. In 2022, global % sales of Non-Benzodiazepines went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-Benzodiazepines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Teva Pharmaceuticals
Torrent Pharma
Accord Healthcare
Akorn
Apotex
Fresenius Kabi
Hikma
Mylan
Par Pharmaceuticals
Sandoz
Sun Pharma
WG Critical Care
Athenex
Chenxin Pharmaceutical
Huatai Chenguang Pharmaceutical
Segment by Type
Dexmedetomidine
Zolpidem
Eszopiclone
Zopiclone
other

Segment by Application


Hospital
Clinic
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Non-Benzodiazepines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Non-Benzodiazepines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Non-Benzodiazepines industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Non-Benzodiazepines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Non-Benzodiazepines introduction, etc. Non-Benzodiazepines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Non-Benzodiazepines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Non-Benzodiazepines Market Overview
1.1 Non-Benzodiazepines Product Overview
1.2 Non-Benzodiazepines Market Segment by Type
1.2.1 Dexmedetomidine
1.2.2 Zolpidem
1.2.3 Eszopiclone
1.2.4 Zopiclone
1.2.5 other
1.3 Global Non-Benzodiazepines Market Size by Type
1.3.1 Global Non-Benzodiazepines Market Size Overview by Type (2024-2034)
1.3.2 Global Non-Benzodiazepines Historic Market Size Review by Type (2024-2024)
1.3.3 Global Non-Benzodiazepines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Non-Benzodiazepines Sales Breakdown by Type (2024-2024)
1.4.2 Europe Non-Benzodiazepines Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Non-Benzodiazepines Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Non-Benzodiazepines Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Non-Benzodiazepines Sales Breakdown by Type (2024-2024)
2 Global Non-Benzodiazepines Market Competition by Company
2.1 Global Top Players by Non-Benzodiazepines Sales (2024-2024)
2.2 Global Top Players by Non-Benzodiazepines Revenue (2024-2024)
2.3 Global Top Players by Non-Benzodiazepines Price (2024-2024)
2.4 Global Top Manufacturers Non-Benzodiazepines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Non-Benzodiazepines Market Competitive Situation and Trends
2.5.1 Non-Benzodiazepines Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Non-Benzodiazepines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-Benzodiazepines as of 2022)
2.7 Date of Key Manufacturers Enter into Non-Benzodiazepines Market
2.8 Key Manufacturers Non-Benzodiazepines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Non-Benzodiazepines Status and Outlook by Region
3.1 Global Non-Benzodiazepines Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Non-Benzodiazepines Historic Market Size by Region
3.2.1 Global Non-Benzodiazepines Sales in Volume by Region (2024-2024)
3.2.2 Global Non-Benzodiazepines Sales in Value by Region (2024-2024)
3.2.3 Global Non-Benzodiazepines Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Non-Benzodiazepines Forecasted Market Size by Region
3.3.1 Global Non-Benzodiazepines Sales in Volume by Region (2024-2034)
3.3.2 Global Non-Benzodiazepines Sales in Value by Region (2024-2034)
3.3.3 Global Non-Benzodiazepines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Non-Benzodiazepines by Application
4.1 Non-Benzodiazepines Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Non-Benzodiazepines Market Size by Application
4.2.1 Global Non-Benzodiazepines Market Size Overview by Application (2024-2034)
4.2.2 Global Non-Benzodiazepines Historic Market Size Review by Application (2024-2024)
4.2.3 Global Non-Benzodiazepines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Non-Benzodiazepines Sales Breakdown by Application (2024-2024)
4.3.2 Europe Non-Benzodiazepines Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Non-Benzodiazepines Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Non-Benzodiazepines Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Non-Benzodiazepines Sales Breakdown by Application (2024-2024)
5 North America Non-Benzodiazepines by Country
5.1 North America Non-Benzodiazepines Historic Market Size by Country
5.1.1 North America Non-Benzodiazepines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Non-Benzodiazepines Sales in Volume by Country (2024-2024)
5.1.3 North America Non-Benzodiazepines Sales in Value by Country (2024-2024)
5.2 North America Non-Benzodiazepines Forecasted Market Size by Country
5.2.1 North America Non-Benzodiazepines Sales in Volume by Country (2024-2034)
5.2.2 North America Non-Benzodiazepines Sales in Value by Country (2024-2034)
6 Europe Non-Benzodiazepines by Country
6.1 Europe Non-Benzodiazepines Historic Market Size by Country
6.1.1 Europe Non-Benzodiazepines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Non-Benzodiazepines Sales in Volume by Country (2024-2024)
6.1.3 Europe Non-Benzodiazepines Sales in Value by Country (2024-2024)
6.2 Europe Non-Benzodiazepines Forecasted Market Size by Country
6.2.1 Europe Non-Benzodiazepines Sales in Volume by Country (2024-2034)
6.2.2 Europe Non-Benzodiazepines Sales in Value by Country (2024-2034)
7 Asia-Pacific Non-Benzodiazepines by Region
7.1 Asia-Pacific Non-Benzodiazepines Historic Market Size by Region
7.1.1 Asia-Pacific Non-Benzodiazepines Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Non-Benzodiazepines Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Non-Benzodiazepines Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Non-Benzodiazepines Forecasted Market Size by Region
7.2.1 Asia-Pacific Non-Benzodiazepines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Non-Benzodiazepines Sales in Value by Region (2024-2034)
8 Latin America Non-Benzodiazepines by Country
8.1 Latin America Non-Benzodiazepines Historic Market Size by Country
8.1.1 Latin America Non-Benzodiazepines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Non-Benzodiazepines Sales in Volume by Country (2024-2024)
8.1.3 Latin America Non-Benzodiazepines Sales in Value by Country (2024-2024)
8.2 Latin America Non-Benzodiazepines Forecasted Market Size by Country
8.2.1 Latin America Non-Benzodiazepines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Non-Benzodiazepines Sales in Value by Country (2024-2034)
9 Middle East and Africa Non-Benzodiazepines by Country
9.1 Middle East and Africa Non-Benzodiazepines Historic Market Size by Country
9.1.1 Middle East and Africa Non-Benzodiazepines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Non-Benzodiazepines Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Non-Benzodiazepines Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Non-Benzodiazepines Forecasted Market Size by Country
9.2.1 Middle East and Africa Non-Benzodiazepines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Non-Benzodiazepines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Pfizer Non-Benzodiazepines Products Offered
10.1.5 Pfizer Recent Development
10.2 Teva Pharmaceuticals
10.2.1 Teva Pharmaceuticals Company Information
10.2.2 Teva Pharmaceuticals Introduction and Business Overview
10.2.3 Teva Pharmaceuticals Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Teva Pharmaceuticals Non-Benzodiazepines Products Offered
10.2.5 Teva Pharmaceuticals Recent Development
10.3 Torrent Pharma
10.3.1 Torrent Pharma Company Information
10.3.2 Torrent Pharma Introduction and Business Overview
10.3.3 Torrent Pharma Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Torrent Pharma Non-Benzodiazepines Products Offered
10.3.5 Torrent Pharma Recent Development
10.4 Accord Healthcare
10.4.1 Accord Healthcare Company Information
10.4.2 Accord Healthcare Introduction and Business Overview
10.4.3 Accord Healthcare Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Accord Healthcare Non-Benzodiazepines Products Offered
10.4.5 Accord Healthcare Recent Development
10.5 Akorn
10.5.1 Akorn Company Information
10.5.2 Akorn Introduction and Business Overview
10.5.3 Akorn Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Akorn Non-Benzodiazepines Products Offered
10.5.5 Akorn Recent Development
10.6 Apotex
10.6.1 Apotex Company Information
10.6.2 Apotex Introduction and Business Overview
10.6.3 Apotex Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Apotex Non-Benzodiazepines Products Offered
10.6.5 Apotex Recent Development
10.7 Fresenius Kabi
10.7.1 Fresenius Kabi Company Information
10.7.2 Fresenius Kabi Introduction and Business Overview
10.7.3 Fresenius Kabi Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Fresenius Kabi Non-Benzodiazepines Products Offered
10.7.5 Fresenius Kabi Recent Development
10.8 Hikma
10.8.1 Hikma Company Information
10.8.2 Hikma Introduction and Business Overview
10.8.3 Hikma Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Hikma Non-Benzodiazepines Products Offered
10.8.5 Hikma Recent Development
10.9 Mylan
10.9.1 Mylan Company Information
10.9.2 Mylan Introduction and Business Overview
10.9.3 Mylan Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Mylan Non-Benzodiazepines Products Offered
10.9.5 Mylan Recent Development
10.10 Par Pharmaceuticals
10.10.1 Par Pharmaceuticals Company Information
10.10.2 Par Pharmaceuticals Introduction and Business Overview
10.10.3 Par Pharmaceuticals Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Par Pharmaceuticals Non-Benzodiazepines Products Offered
10.10.5 Par Pharmaceuticals Recent Development
10.11 Sandoz
10.11.1 Sandoz Company Information
10.11.2 Sandoz Introduction and Business Overview
10.11.3 Sandoz Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Sandoz Non-Benzodiazepines Products Offered
10.11.5 Sandoz Recent Development
10.12 Sun Pharma
10.12.1 Sun Pharma Company Information
10.12.2 Sun Pharma Introduction and Business Overview
10.12.3 Sun Pharma Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Sun Pharma Non-Benzodiazepines Products Offered
10.12.5 Sun Pharma Recent Development
10.13 WG Critical Care
10.13.1 WG Critical Care Company Information
10.13.2 WG Critical Care Introduction and Business Overview
10.13.3 WG Critical Care Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.13.4 WG Critical Care Non-Benzodiazepines Products Offered
10.13.5 WG Critical Care Recent Development
10.14 Athenex
10.14.1 Athenex Company Information
10.14.2 Athenex Introduction and Business Overview
10.14.3 Athenex Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Athenex Non-Benzodiazepines Products Offered
10.14.5 Athenex Recent Development
10.15 Chenxin Pharmaceutical
10.15.1 Chenxin Pharmaceutical Company Information
10.15.2 Chenxin Pharmaceutical Introduction and Business Overview
10.15.3 Chenxin Pharmaceutical Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Chenxin Pharmaceutical Non-Benzodiazepines Products Offered
10.15.5 Chenxin Pharmaceutical Recent Development
10.16 Huatai Chenguang Pharmaceutical
10.16.1 Huatai Chenguang Pharmaceutical Company Information
10.16.2 Huatai Chenguang Pharmaceutical Introduction and Business Overview
10.16.3 Huatai Chenguang Pharmaceutical Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Huatai Chenguang Pharmaceutical Non-Benzodiazepines Products Offered
10.16.5 Huatai Chenguang Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Non-Benzodiazepines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Non-Benzodiazepines Industrial Chain Analysis
11.4 Non-Benzodiazepines Market Dynamics
11.4.1 Non-Benzodiazepines Industry Trends
11.4.2 Non-Benzodiazepines Market Drivers
11.4.3 Non-Benzodiazepines Market Challenges
11.4.4 Non-Benzodiazepines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Non-Benzodiazepines Distributors
12.3 Non-Benzodiazepines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Dexmedetomidine
Table 2. Major Company of Zolpidem
Table 3. Major Company of Eszopiclone
Table 4. Major Company of Zopiclone
Table 5. Major Company of other
Table 6. Global Non-Benzodiazepines Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Non-Benzodiazepines Sales by Type (2024-2024) & (K Units)
Table 8. Global Non-Benzodiazepines Sales Market Share in Volume by Type (2024-2024)
Table 9. Global Non-Benzodiazepines Sales by Type (2024-2024) & (US& Million)
Table 10. Global Non-Benzodiazepines Market Share in Value by Type (2024-2024)
Table 11. Global Non-Benzodiazepines Price by Type (2024-2024) & (US$/Unit)
Table 12. Global Non-Benzodiazepines Sales by Type (2024-2034) & (K Units)
Table 13. Global Non-Benzodiazepines Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Non-Benzodiazepines Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Non-Benzodiazepines Sales Market Share in Value by Type (2024-2034)
Table 16. Global Non-Benzodiazepines Price by Type (2024-2034) & (US$/Unit)
Table 17. North America Non-Benzodiazepines Sales by Type (2024-2024) & (K Units)
Table 18. North America Non-Benzodiazepines Sales by Type (2024-2024) & (US$ Million)
Table 19. Europe Non-Benzodiazepines Sales (K Units) by Type (2024-2024)
Table 20. Europe Non-Benzodiazepines Sales by Type (2024-2024) & (US$ Million)
Table 21. Asia-Pacific Non-Benzodiazepines Sales (K Units) by Type (2024-2024)
Table 22. Asia-Pacific Non-Benzodiazepines Sales by Type (2024-2024) & (US$ Million)
Table 23. Latin America Non-Benzodiazepines Sales (K Units) by Type (2024-2024)
Table 24. Latin America Non-Benzodiazepines Sales by Type (2024-2024) & (US$ Million)
Table 25. Middle East and Africa Non-Benzodiazepines Sales (K Units) by Type (2024-2024)
Table 26. Middle East and Africa Non-Benzodiazepines Sales by Type (2024-2024) & (US$ Million)
Table 27. Global Non-Benzodiazepines Sales by Company (2024-2024) & (K Units)
Table 28. Global Non-Benzodiazepines Sales Share by Company (2024-2024)
Table 29. Global Non-Benzodiazepines Revenue by Company (2024-2024) & (US$ Million)
Table 30. Global Non-Benzodiazepines Revenue Share by Company (2024-2024)
Table 31. Global Market Non-Benzodiazepines Price by Company (2024-2024) & (US$/Unit)
Table 32. Global Non-Benzodiazepines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Non-Benzodiazepines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-Benzodiazepines as of 2022)
Table 35. Date of Key Manufacturers Enter into Non-Benzodiazepines Market
Table 36. Key Manufacturers Non-Benzodiazepines Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Non-Benzodiazepines Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Global Non-Benzodiazepines Sales by Region (2024-2024) & (K Units)
Table 40. Global Non-Benzodiazepines Sales Market Share in Volume by Region (2024-2024)
Table 41. Global Non-Benzodiazepines Sales by Region (2024-2024) & (US$ Million)
Table 42. Global Non-Benzodiazepines Sales Market Share in Value by Region (2024-2024)
Table 43. Global Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 44. Global Non-Benzodiazepines Sales by Region (2024-2034) & (K Units)
Table 45. Global Non-Benzodiazepines Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Non-Benzodiazepines Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Non-Benzodiazepines Sales Market Share in Value by Region (2024-2034)
Table 48. Global Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 49. Global Non-Benzodiazepines Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 50. Global Non-Benzodiazepines Sales by Application (2024-2024) & (K Units)
Table 51. Global Non-Benzodiazepines Sales Market Share in Volume by Application (2024-2024)
Table 52. Global Non-Benzodiazepines Sales by Application (2024-2024) & (US$ Million)
Table 53. Global Non-Benzodiazepines Sales Market Share in Value by Application (2024-2024)
Table 54. Global Non-Benzodiazepines Price by Application (2024-2024) & (US$/Unit)
Table 55. Global Non-Benzodiazepines Sales by Application (2024-2034) & (K Units)
Table 56. Global Non-Benzodiazepines Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Non-Benzodiazepines Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Non-Benzodiazepines Sales Market Share in Value by Application (2024-2034)
Table 59. Global Non-Benzodiazepines Price by Application (2024-2034) & (US$/Unit)
Table 60. North America Non-Benzodiazepines Sales by Application (2024-2024) (K Units)
Table 61. North America Non-Benzodiazepines Sales by Application (2024-2024) & (US$ Million)
Table 62. Europe Non-Benzodiazepines Sales by Application (2024-2024) (K Units)
Table 63. Europe Non-Benzodiazepines Sales by Application (2024-2024) & (US$ Million)
Table 64. Asia-Pacific Non-Benzodiazepines Sales by Application (2024-2024) (K Units)
Table 65. Asia-Pacific Non-Benzodiazepines Sales by Application (2024-2024) & (US$ Million)
Table 66. Latin America Non-Benzodiazepines Sales by Application (2024-2024) (K Units)
Table 67. Latin America Non-Benzodiazepines Sales by Application (2024-2024) & (US$ Million)
Table 68. Middle East and Africa Non-Benzodiazepines Sales by Application (2024-2024) (K Units)
Table 69. Middle East and Africa Non-Benzodiazepines Sales by Application (2024-2024) & (US$ Million)
Table 70. North America Non-Benzodiazepines Sales by Country (2024-2024) & (K Units)
Table 71. North America Non-Benzodiazepines Sales Market Share in Volume by Country (2024-2024)
Table 72. North America Non-Benzodiazepines Sales by Country (2024-2024) & (US$ Million)
Table 73. North America Non-Benzodiazepines Sales Market Share in Value by Country (2024-2024)
Table 74. North America Non-Benzodiazepines Sales by Country (2024-2034) & (K Units)
Table 75. North America Non-Benzodiazepines Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Non-Benzodiazepines Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Non-Benzodiazepines Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Non-Benzodiazepines Sales by Country (2024-2024) & (K Units)
Table 79. Europe Non-Benzodiazepines Sales Market Share in Volume by Country (2024-2024)
Table 80. Europe Non-Benzodiazepines Sales by Country (2024-2024) & (US$ Million)
Table 81. Europe Non-Benzodiazepines Sales Market Share in Value by Country (2024-2024)
Table 82. Europe Non-Benzodiazepines Sales by Country (2024-2034) & (K Units)
Table 83. Europe Non-Benzodiazepines Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Non-Benzodiazepines Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Non-Benzodiazepines Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Non-Benzodiazepines Sales by Region (2024-2024) & (K Units)
Table 87. Asia-Pacific Non-Benzodiazepines Sales Market Share in Volume by Region (2024-2024)
Table 88. Asia-Pacific Non-Benzodiazepines Sales by Region (2024-2024) & (US$ Million)
Table 89. Asia-Pacific Non-Benzodiazepines Sales Market Share in Value by Region (2024-2024)
Table 90. Asia-Pacific Non-Benzodiazepines Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Non-Benzodiazepines Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Non-Benzodiazepines Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Non-Benzodiazepines Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Non-Benzodiazepines Sales by Country (2024-2024) & (K Units)
Table 95. Latin America Non-Benzodiazepines Sales Market Share in Volume by Country (2024-2024)
Table 96. Latin America Non-Benzodiazepines Sales by Country (2024-2024) & (US$ Million)
Table 97. Latin America Non-Benzodiazepines Sales Market Share in Value by Country (2024-2024)
Table 98. Latin America Non-Benzodiazepines Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Non-Benzodiazepines Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Non-Benzodiazepines Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Non-Benzodiazepines Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Non-Benzodiazepines Sales by Country (2024-2024) & (K Units)
Table 103. Middle East and Africa Non-Benzodiazepines Sales Market Share in Volume by Country (2024-2024)
Table 104. Middle East and Africa Non-Benzodiazepines Sales by Country (2024-2024) & (US$ Million)
Table 105. Middle East and Africa Non-Benzodiazepines Sales Market Share in Value by Country (2024-2024)
Table 106. Middle East and Africa Non-Benzodiazepines Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Non-Benzodiazepines Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Non-Benzodiazepines Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Non-Benzodiazepines Sales Market Share in Value by Country (2024-2034)
Table 110. Pfizer Company Information
Table 111. Pfizer Introduction and Business Overview
Table 112. Pfizer Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Pfizer Non-Benzodiazepines Product
Table 114. Pfizer Recent Development
Table 115. Teva Pharmaceuticals Company Information
Table 116. Teva Pharmaceuticals Introduction and Business Overview
Table 117. Teva Pharmaceuticals Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Teva Pharmaceuticals Non-Benzodiazepines Product
Table 119. Teva Pharmaceuticals Recent Development
Table 120. Torrent Pharma Company Information
Table 121. Torrent Pharma Introduction and Business Overview
Table 122. Torrent Pharma Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Torrent Pharma Non-Benzodiazepines Product
Table 124. Torrent Pharma Recent Development
Table 125. Accord Healthcare Company Information
Table 126. Accord Healthcare Introduction and Business Overview
Table 127. Accord Healthcare Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Accord Healthcare Non-Benzodiazepines Product
Table 129. Accord Healthcare Recent Development
Table 130. Akorn Company Information
Table 131. Akorn Introduction and Business Overview
Table 132. Akorn Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Akorn Non-Benzodiazepines Product
Table 134. Akorn Recent Development
Table 135. Apotex Company Information
Table 136. Apotex Introduction and Business Overview
Table 137. Apotex Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Apotex Non-Benzodiazepines Product
Table 139. Apotex Recent Development
Table 140. Fresenius Kabi Company Information
Table 141. Fresenius Kabi Introduction and Business Overview
Table 142. Fresenius Kabi Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Fresenius Kabi Non-Benzodiazepines Product
Table 144. Fresenius Kabi Recent Development
Table 145. Hikma Company Information
Table 146. Hikma Introduction and Business Overview
Table 147. Hikma Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Hikma Non-Benzodiazepines Product
Table 149. Hikma Recent Development
Table 150. Mylan Company Information
Table 151. Mylan Introduction and Business Overview
Table 152. Mylan Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Mylan Non-Benzodiazepines Product
Table 154. Mylan Recent Development
Table 155. Par Pharmaceuticals Company Information
Table 156. Par Pharmaceuticals Introduction and Business Overview
Table 157. Par Pharmaceuticals Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. Par Pharmaceuticals Non-Benzodiazepines Product
Table 159. Par Pharmaceuticals Recent Development
Table 160. Sandoz Company Information
Table 161. Sandoz Introduction and Business Overview
Table 162. Sandoz Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 163. Sandoz Non-Benzodiazepines Product
Table 164. Sandoz Recent Development
Table 165. Sun Pharma Company Information
Table 166. Sun Pharma Introduction and Business Overview
Table 167. Sun Pharma Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 168. Sun Pharma Non-Benzodiazepines Product
Table 169. Sun Pharma Recent Development
Table 170. WG Critical Care Company Information
Table 171. WG Critical Care Introduction and Business Overview
Table 172. WG Critical Care Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 173. WG Critical Care Non-Benzodiazepines Product
Table 174. WG Critical Care Recent Development
Table 175. Athenex Company Information
Table 176. Athenex Introduction and Business Overview
Table 177. Athenex Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 178. Athenex Non-Benzodiazepines Product
Table 179. Athenex Recent Development
Table 180. Chenxin Pharmaceutical Company Information
Table 181. Chenxin Pharmaceutical Introduction and Business Overview
Table 182. Chenxin Pharmaceutical Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 183. Chenxin Pharmaceutical Non-Benzodiazepines Product
Table 184. Chenxin Pharmaceutical Recent Development
Table 185. Huatai Chenguang Pharmaceutical Company Information
Table 186. Huatai Chenguang Pharmaceutical Introduction and Business Overview
Table 187. Huatai Chenguang Pharmaceutical Non-Benzodiazepines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 188. Huatai Chenguang Pharmaceutical Non-Benzodiazepines Product
Table 189. Huatai Chenguang Pharmaceutical Recent Development
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Non-Benzodiazepines Market Trends
Table 193. Non-Benzodiazepines Market Drivers
Table 194. Non-Benzodiazepines Market Challenges
Table 195. Non-Benzodiazepines Market Restraints
Table 196. Non-Benzodiazepines Distributors List
Table 197. Non-Benzodiazepines Downstream Customers
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-Benzodiazepines Product Picture
Figure 2. Global Non-Benzodiazepines Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Non-Benzodiazepines Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Non-Benzodiazepines Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Dexmedetomidine
Figure 6. Global Dexmedetomidine Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Zolpidem
Figure 8. Global Zolpidem Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Eszopiclone
Figure 10. Global Eszopiclone Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Zopiclone
Figure 12. Global Zopiclone Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of other
Figure 14. Global other Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Global Non-Benzodiazepines Sales by Type (2024-2034) & (US$ Million)
Figure 16. Global Non-Benzodiazepines Sales Market Share by Type in 2022 & 2034
Figure 17. North America Non-Benzodiazepines Sales Market Share in Volume by Type in 2022
Figure 18. North America Non-Benzodiazepines Sales Market Share in Value by Type in 2022
Figure 19. Europe Non-Benzodiazepines Sales Market Share in Volume by Type in 2022
Figure 20. Europe Non-Benzodiazepines Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Non-Benzodiazepines Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Non-Benzodiazepines Sales Market Share in Value by Type in 2022
Figure 23. Latin America Non-Benzodiazepines Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Non-Benzodiazepines Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Non-Benzodiazepines Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Non-Benzodiazepines Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-Benzodiazepines Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-Benzodiazepines Revenue in 2022
Figure 29. Non-Benzodiazepines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Product Picture of Hospital
Figure 31. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Clinic
Figure 33. Global Clinic Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Global Non-Benzodiazepines Sales by Application (2024-2034) & (US$ Million)
Figure 37. Global Non-Benzodiazepines Sales Market Share by Application in 2022 & 2034
Figure 38. North America Non-Benzodiazepines Sales Market Share in Volume by Application in 2022
Figure 39. North America Non-Benzodiazepines Sales Market Share in Value by Application in 2022
Figure 40. Europe Non-Benzodiazepines Sales Market Share in Volume by Application in 2022
Figure 41. Europe Non-Benzodiazepines Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Non-Benzodiazepines Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Non-Benzodiazepines Sales Market Share in Value by Application in 2022
Figure 44. Latin America Non-Benzodiazepines Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Non-Benzodiazepines Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Non-Benzodiazepines Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Non-Benzodiazepines Manufacturing Cost Structure
Figure 49. Non-Benzodiazepines Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries